
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
GlobalData's latest report says the Chronic Obstructive Pulmonary Disease pipeline is lagging in terms of first-in-class product innovation when it comes to asthma.
Read more about it






